Slamon, D. J., Neven, P., Chia, S., Fasching, P. A., De Laurentiis, M., Im, S., . . . Jerusalem, G. (2018). Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3. Journal of clinical oncology, 36(24), 2465. https://doi.org/10.1200/JCO.2018.78.9909
Citace podle Chicago (17th ed.)Slamon, Dennis J., et al. "Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3." Journal of Clinical Oncology 36, no. 24 (2018): 2465. https://doi.org/10.1200/JCO.2018.78.9909.
Citace podle MLA (9th ed.)Slamon, Dennis J., et al. "Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3." Journal of Clinical Oncology, vol. 36, no. 24, 2018, p. 2465, https://doi.org/10.1200/JCO.2018.78.9909.